Sequana Medical
Ghent, BE Β· 9 known investors
Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure. It is a publicly listed medical device company addressing unmet needs in the management of ascites and related conditions.
Investors Β· 9
Newton Biocapitalβ verifiedBrussels
BlackRockβ verifiedWilmington
EQT Life Sciencesβ verifiedLuxembourg Β· $11M β $66M
Kreos Capitalβ verifiedLondon
Rosetta Capital Ltd.β verifiedOxford
VI Partnersβ verifiedAltendorf Β· $2.2M β $4.5M
Bootstrap EuropeLondon
PMVBrussels
The Global Emerging Markets Group (GEM)New York